Send mail to Author

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _    _      ___     __   __   __   __    ______   _    _   
| \  / ||   / _ \\   \ \\/ //  \ \\/ //  /_   _// | || | || 
|  \/  ||  / //\ \\   \   //    \ ` //   `-| |,-  | || | || 
| .  . || |  ___  ||  / . \\     | ||      | ||   | \\_/ || 
|_|\/|_|| |_||  |_|| /_//\_\\    |_||      |_||    \____//  
`-`  `-`  `-`   `-`  `-`  --`    `-`'      `-`'     `---`
 


Back to frontdoor view

OPUS4 Logo